Newsroom

Home / Newsroom / CBMG Announces Positive Results from CAR-T EGFR Immunotherapy in Advanced Relapsed/Refractory Patients with Solid Tumors
28Sep

CBMG Announces Positive Results from CAR-T EGFR Immunotherapy in Advanced Relapsed/Refractory Patients with Solid Tumors

Download Full Article as .PDF (Size: 179 kB)

This CBMG article was posted on 28 Sep 2015